{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:27:45Z","timestamp":1782739665075,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T00:00:00Z","timestamp":1353888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Despite the widely accepted association between crusted scabies and human immunodeficiency virus (HIV)-infection, crusted scabies has not been included in the spectrum of infections associated with immune reconstitution inflammatory syndrome in HIV-infected patients initiating antiretroviral therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report a case of a 28-year-old Mexican individual with late HIV-infection, who had no apparent skin lesions but soon after initiation of antiretroviral therapy, he developed an aggressive form of crusted scabies with rapid progression of lesions. Severe infestation by<jats:italic>Sarcoptes scabiei<\/jats:italic>was confirmed by microscopic examination of the scale and skin biopsy. Due to the atypical presentation of scabies in a patient responding to antiretroviral therapy, preceded by no apparent skin lesions at initiation of antiretroviral therapy, the episode was interpreted for the first time as \u201cunmasking crusted scabies-associated immune reconstitution inflammatory syndrome\u201d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case illustrates that when crusted scabies is observed in HIV-infected patients responding to antiretroviral therapy, it might as well be considered as a possible manifestation of immune reconstitution inflammatory syndrome. Patient context should be considered for adequate diagnosis and treatment of conditions exacerbated by antiretroviral therapy-induced immune reconstitution.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2334-12-323","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T02:03:07Z","timestamp":1353981787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Crusted scabies-associated immune reconstitution inflammatory syndrome"],"prefix":"10.1186","volume":"12","author":[{"given":"M\u00f3nica","family":"Fern\u00e1ndez-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Saeb-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Alvarado-de la Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Reyes-Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,26]]},"reference":[{"key":"2250_CR1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-3024.2010.01218.x","volume":"32","author":"SF Walton","year":"2010","unstructured":"Walton SF: The immunology of susceptibility and resistance to scabies. Parasite Immunol. 2010, 32: 532-540.","journal-title":"Parasite Immunol"},{"key":"2250_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/00007611-199403000-00011","volume":"87","author":"I Schlesinger","year":"1996","unstructured":"Schlesinger I, Oelrich DM, Tyring SK: Crusted (Norwegian) scabies in patients with AIDS: The range of clinical presentations. South Med J. 1996, 87: 352-356.","journal-title":"South Med J"},{"key":"2250_CR3","first-page":"9","volume":"12","author":"M Orkin","year":"1993","unstructured":"Orkin M: Scabies in AIDS. Semin Dermatol. 1993, 12: 9-14.","journal-title":"Semin Dermatol"},{"key":"2250_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","volume":"10","author":"M M\u00fcller","year":"2010","unstructured":"M\u00fcller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M: Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010, 10: 251-261. 10.1016\/S1473-3099(10)70026-8.","journal-title":"Lancet Infect Dis"},{"key":"2250_CR5","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","volume":"18","author":"MA French","year":"2004","unstructured":"French MA, Price P, Stone SF: Immune restoration disease after antiretroviral therapy. AIDS. 2004, 18: 1615-1627. 10.1097\/01.aids.0000131375.21070.06.","journal-title":"AIDS"},{"key":"2250_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","volume":"8","author":"G Meintjes","year":"2008","unstructured":"Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, Elliott JH, Murdoch D, Wilkinson RJ, Seyler C, John L, van der Loeff MS, Reiss P, Lynen L, Janoff EN, Gilks C, Colebunders R, International Network for the Study of HIV-associated IRIS: Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008, 8: 516-523. 10.1016\/S1473-3099(08)70184-1.","journal-title":"Lancet Infect Dis"},{"key":"2250_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/0140-6736(90)92754-6","volume":"335","author":"G Sirera","year":"1990","unstructured":"Sirera G, Rius F, Romeu J, Llibre J, Ribera M, Soriano V, Tor J, Ferrandiz C, Clotet B: Hospital outbreak of scabies stemming from two AIDS patients with Norwegian scabies. Lancet. 1990, 335: 1227-","journal-title":"Lancet"},{"key":"2250_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-6405-4-9","volume":"4","author":"DM Murdoch","year":"2007","unstructured":"Murdoch DM, Venter WD, Van Rie A, Feldman C: Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Research and Therapy. 2007, 4: 9-10.1186\/1742-6405-4-9. http:\/\/www.aidsrestherapy.com\/content\/pdf\/1742-6405-4-9.pdf.","journal-title":"AIDS Research and Therapy"},{"key":"2250_CR9","first-page":"152","volume":"13","author":"MJ Jim\u00e9nez-Exp\u00f3sito","year":"1999","unstructured":"Jim\u00e9nez-Exp\u00f3sito MJ, Alonso-Villaverde C, Sard\u00e0 P, Masana L: Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy. AIDS. 1999, 13: 152-153.","journal-title":"AIDS"},{"key":"2250_CR10","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1086\/428099","volume":"191","author":"M Lanzafame","year":"2005","unstructured":"Lanzafame M, Faggian F, Lattuada E, Antolini D, Vento S: Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration. J Infect Dis. 2005, 191: 1027-10.1086\/428099.","journal-title":"J Infect Dis"},{"key":"2250_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/499109","volume":"42","author":"S de Silva","year":"2006","unstructured":"de Silva S, Walsh J, Brown M: Symptomatic Schistosoma mansoni infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy. Clin Infect Dis. 2006, 42: 303-304. 10.1086\/499109.","journal-title":"Clin Infect Dis"},{"key":"2250_CR12","first-page":"615","volume":"11","author":"PE Tsambiras","year":"2001","unstructured":"Tsambiras PE, Larkin JA, Houston SH: Case report. Toxoplasma encephalitis after initiation of HAART. AIDS Read. 2001, 11: 615-616.","journal-title":"AIDS Read"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-323\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T02:15:54Z","timestamp":1714616154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,26]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2250"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-323","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,26]]},"assertion":[{"value":"13 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"323"}}